NIH-funded research R01 grant

Improving Risk Stratification for Familial Hypercholesterolemia (FH)

Official title: Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)

Funded at Geisinger Clinic · NIH-11379914 · Data updated 2026-11-12

A patient-facing look at a study that aims to better predict who with familial hypercholesterolemia is at highest risk for early heart disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGeisinger Clinic
NIH-funded
Lab location1 site (Danville, United States)
Project startJuly 1, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$722,234
NIH project number5R01HL159182-05
Project IDNIH-11379914 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with a diagnosis or suspicion of familial hypercholesterolemia and a need for improved risk assessment.

Less likely to help

Patients without FH or those not affected by elevated ASCVD risk may not benefit from this study.

What this research studies

This project will examine how genetic factors, cholesterol levels, and other health information come together to predict heart-disease risk in people with familial hypercholesterolemia. Researchers will analyze different FH subtypes and how they relate to future ASCVD risk, aiming to improve how we judge who needs more aggressive treatment. The study plans to integrate genetic data, lipoprotein(a) levels, family history, and existing health factors to refine risk estimates. Results could guide doctors in tailoring treatment decisions and communication about risk to patients. Participants may see findings that help personalize care and prevent early cardiovascular events.

Why it matters

Potential benefit: If successful, the study could lead to more precise risk predictions and personalized treatment plans for FH patients to prevent heart disease.

How similar studies have gone: Prior research supports that FH has subtypes and variable risk; this project seeks to refine risk prediction in a similar area.

Where this research is happening

  • Geisinger Clinic
    Danville, United States
    Active

Researchers

  • Principal investigator: Oetjens, Matthew — Geisinger Clinic
  • Study coordinator: Oetjens, Matthew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.